{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T20:06:50Z","timestamp":1775592410039,"version":"3.50.1"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biol Inorg Chem"],"DOI":"10.1007\/s00775-023-02030-0","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T16:02:37Z","timestamp":1702656157000},"page":"51-73","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Characterization, modes of interactions with DNA\/BSA biomolecules and anti-tumor activity of newly synthesized dinuclear platinum(II) complexes with pyridazine bridging ligand"],"prefix":"10.1007","volume":"29","author":[{"given":"Sanja","family":"Zorni\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bojana","family":"Simovi\u0107 Markovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andjela A.","family":"Franich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goran V.","family":"Janji\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milka B.","family":"Jadranin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelena","family":"Avdalovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sne\u017eana","family":"Rajkovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija D.","family":"\u017divkovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neboj\u0161a N.","family":"Arsenijevi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordana D.","family":"Radosavljevi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelena","family":"Panti\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,15]]},"reference":[{"issue":"3","key":"2030_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"2030_CR2","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00280-016-2976-z","volume":"77","author":"S Dilruba","year":"2016","unstructured":"Dilruba S, Kalayda GV (2016) Platinum-based drugs: past, present and future. Cancer Chemother Pharmacol 77(6):1103\u20131124. https:\/\/doi.org\/10.1007\/s00280-016-2976-z","journal-title":"Cancer Chemother Pharmacol"},{"key":"2030_CR3","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1021\/cr980421n","volume":"99","author":"ER Jamieson","year":"1999","unstructured":"Jamieson ER, Lippard SJ (1999) Structure, recognition, and processing of cisplatin-DNA adducts. Chem Rev 99:2467\u20132498. https:\/\/doi.org\/10.1021\/cr980421n","journal-title":"Chem Rev"},{"key":"2030_CR4","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1039\/B907567D","volume":"1","author":"RC Todd","year":"2009","unstructured":"Todd RC, Lippard SJ (2009) Inhibition of transcription by platinum antitumor compounds. Metallomics 1:280\u2013291. https:\/\/doi.org\/10.1039\/B907567D","journal-title":"Metallomics"},{"key":"2030_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejmech.2017.04.007","volume":"142","author":"T Lazarevi\u0107","year":"2017","unstructured":"Lazarevi\u0107 T, Rilak A, Bugar\u010di\u0107 \u017d (2017) Platinum, palladium, gold and ruthenium complexes as anticancer agents: current clinical uses, cytotoxicity studies and future perspectives. Eur J Med Chem 142:8\u201331. https:\/\/doi.org\/10.1016\/j.ejmech.2017.04.007","journal-title":"Eur J Med Chem"},{"key":"2030_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1039\/A815001","volume":"15","author":"S Neidle","year":"1998","unstructured":"Neidle S, Nunn CM (1998) Crystal structures of nucleic acids and their drug complexes. Nat Prod Rep 15:1\u201315. https:\/\/doi.org\/10.1039\/A815001","journal-title":"Nat Prod Rep"},{"issue":"5","key":"2030_CR7","doi-asserted-by":"publisher","first-page":"551","DOI":"10.2174\/0929867003373337","volume":"8","author":"X Han","year":"2001","unstructured":"Han X, Gao X (2001) Sequence specific recognition of ligand-DNA complexes studied by NMR. Curr Med Chem 8(5):551\u2013581. https:\/\/doi.org\/10.2174\/0929867003373337","journal-title":"Curr Med Chem"},{"key":"2030_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ica.2016.04.052","volume":"452","author":"SI Komeda","year":"2016","unstructured":"Komeda SI, Qu Y, Mangrum JB, Hegmans A, Williams LD, Farrell NP (2016) The phosphate clamp as recognition motif in platinum\u2013DNA interactions. Inorg Chim Acta 452:25\u201333. https:\/\/doi.org\/10.1016\/j.ica.2016.04.052","journal-title":"Inorg Chim Acta"},{"issue":"42","key":"2030_CR9","doi-asserted-by":"publisher","first-page":"15091","DOI":"10.1039\/C8DT01946K","volume":"47","author":"B Konovalov","year":"2018","unstructured":"Konovalov B, \u017divkovi\u0107 MD, Milovanovi\u0107 J, Djordjevi\u0107 D, Arsenijevi\u0107 A, Vasi\u0107 I, Janji\u0107 G, Franich A, Manojlovi\u0107 D, Skrivanj S, Milovanovi\u0107 M, Djuran MI, Rajkovi\u0107 S (2018) Synthesis, cytotoxic activity and DNA interaction studies of new dinuclear platinum(II) complexes with an aromatic 1,5-naphthyridine bridging ligand: DNA binding mode of polynuclear platinum(II) complexes in relation to the complex structure. Dalton Trans 47(42):15091\u201315102. https:\/\/doi.org\/10.1039\/C8DT01946K","journal-title":"Dalton Trans"},{"issue":"13","key":"2030_CR10","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1002\/cbic.202000838","volume":"22","author":"NZ Fantoni","year":"2021","unstructured":"Fantoni NZ, Brown T, Kellett A (2021) DNA-targeted metallodrugs: an untapped source of artificial gene editing technology. ChemBioChem 22(13):2184\u20132205. https:\/\/doi.org\/10.1002\/cbic.202000838","journal-title":"ChemBioChem"},{"key":"2030_CR11","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","volume":"740","author":"S Dasari","year":"2014","unstructured":"Dasari S, Tchounwou PB (2014) Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 740:364\u2013378. https:\/\/doi.org\/10.1016\/j.ejphar.2014.07.025","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"2030_CR12","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/cancers3011351","volume":"3","author":"AM Florea","year":"2011","unstructured":"Florea AM, B\u00fcsselberg D (2011) Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers (Basel) 3(1):1351\u20131371. https:\/\/doi.org\/10.3390\/cancers3011351","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2030_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00775-012-0944-6","volume":"18","author":"O D\u00f6m\u00f6t\u00f6r","year":"2013","unstructured":"D\u00f6m\u00f6t\u00f6r O, Hartinger CG, Bytzek AK, Kiss T, Keppler BK, Enyedy EA (2013) Characterization of the binding sites of the anticancer ruthenium(III) complexes KP1019 and KP1339 on human serum albumin via competition studies. J Biol Inorg Chem 18(1):9\u201317. https:\/\/doi.org\/10.1007\/s00775-012-0944-6","journal-title":"J Biol Inorg Chem"},{"issue":"6","key":"2030_CR14","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1021\/cr040704h","volume":"106","author":"AR Timerbaev","year":"2006","unstructured":"Timerbaev AR, Hartinger CG, Aleksenko SS, Keppler BK (2006) Interactions of antitumor metallodrugs with serum proteins: advances in characterization using modern analytical methodology. Chem Rev 106(6):2224\u20132248. https:\/\/doi.org\/10.1021\/cr040704h","journal-title":"Chem Rev"},{"key":"2030_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.molstruc.2003.12.019","volume":"691","author":"J Tian","year":"2004","unstructured":"Tian J, Liu J, Tian X, Hu Z, Chen X (2004) Study of the interaction of kaempferol with bovine serum albumin. J Mol Struct 691:197\u2013202. https:\/\/doi.org\/10.1016\/j.molstruc.2003.12.019","journal-title":"J Mol Struct"},{"issue":"6383","key":"2030_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/358209a0","volume":"358","author":"XM He","year":"1992","unstructured":"He XM, Carter DC (1992) Atomic structure and chemistry of human serum albumin. Nature 358(6383):209\u2013215. https:\/\/doi.org\/10.1038\/358209a0","journal-title":"Nature"},{"issue":"46","key":"2030_CR17","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.1038\/s41388-021-02055-2","volume":"40","author":"D Huang","year":"2021","unstructured":"Huang D, Savage SR, Calinawan AP, Lin C, Zhang B, Wang P, Starr TK, Birrer MJ, Paulovich AG (2021) A highly annotated database of genes associated with platinum resistance in cancer. Oncogene 40(46):6395\u20136405. https:\/\/doi.org\/10.1038\/s41388-021-02055-2","journal-title":"Oncogene"},{"issue":"6","key":"2030_CR18","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00775-017-1459-y","volume":"22","author":"M Arsenijevic","year":"2017","unstructured":"Arsenijevic M, Milovanovic M, Jovanovic S, Arsenijevic N, Markovic BS, Gazdic M, Volarevic V (2017) In vitro and in vivo anti-tumor effects of selected platinum(IV) and dinuclear platinum(II) complexes against lung cancer cells. J Biol Inorg Chem 22(6):807\u2013817. https:\/\/doi.org\/10.1007\/s00775-017-1459-y","journal-title":"J Biol Inorg Chem"},{"key":"2030_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1039\/C7QI00299H","volume":"5","author":"MD \u017divkovi\u0107","year":"2018","unstructured":"\u017divkovi\u0107 MD, Kljun J, Ili\u0107-Tomi\u0107 T, Pavi\u0107 A, Veselinovi\u0107 A, Manojlovi\u0107 DD, Nikodinovi\u0107-Runi\u0107 J, Turel I (2018) A new class of platinum(II) complexes with the phosphine ligand pta which show potent anticancer activity. Inorg Chem Front 5:39\u201353. https:\/\/doi.org\/10.1039\/C7QI00299H","journal-title":"Inorg Chem Front"},{"issue":"44","key":"2030_CR20","doi-asserted-by":"publisher","first-page":"12971","DOI":"10.1002\/slct.201903290","volume":"4","author":"N Markovi\u0107","year":"2019","unstructured":"Markovi\u0107 N, Zari\u0107 M, \u017divkovi\u0107 MD, Rajkovi\u0107 S, Jovanovi\u0107 I, Arsenijevi\u0107 N, \u010canovi\u0107 P, Ninkovi\u0107 S (2019) Novel platinum(II) complexes selectively induced apoptosis and cell cycle arrest of breast cancer cells in vitro. Chem Select 4(44):12971\u201312977. https:\/\/doi.org\/10.1002\/slct.201903290","journal-title":"Chem Select"},{"issue":"7","key":"2030_CR21","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00775-019-01695-w","volume":"24","author":"AA Franich","year":"2019","unstructured":"Franich AA, \u017divkovi\u0107 MD, \u0106o\u0107i\u0107 D, Petrovi\u0107 B, Milovanovi\u0107 M, Arsenijevi\u0107 A, Milovanovi\u0107 J, Arsenijevi\u0107 D, Stojanovi\u0107 B, Djuran MI, Rajkovi\u0107 S (2019) New dinuclear palladium(II) complexes with benzodiazines as bridging ligands: interactions with CT-DNA and BSA, and cytotoxic activity. J Biol Inorg Chem 24(7):1009\u20131022. https:\/\/doi.org\/10.1007\/s00775-019-01695-w","journal-title":"J Biol Inorg Chem"},{"issue":"3","key":"2030_CR22","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00775-020-01770-7","volume":"25","author":"AA Franich","year":"2020","unstructured":"Franich AA, \u017divkovi\u0107 MD, Ili\u0107-Tomi\u0107 T, \u0110or\u0111evi\u0107 IS, Nikodinovi\u0107-Runi\u0107 J, Pavi\u0107 A, Janji\u0107 GV, Rajkovi\u0107 S (2020) New minor groove covering DNA binding mode of dinuclear Pt(II) complexes with various pyridine-linked bridging ligands and dual anticancer-antiangiogenic activities. J Biol Inorg Chem 25(3):395\u2013409. https:\/\/doi.org\/10.1007\/s00775-020-01770-7","journal-title":"J Biol Inorg Chem"},{"key":"2030_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2021.111619","volume":"225","author":"I Vasi\u0107","year":"2021","unstructured":"Vasi\u0107 I, Rajkovi\u0107 S, Arsenijevi\u0107 A, Milovanovi\u0107 M, Arsenijevi\u0107 N, Milovanovi\u0107 J, \u017divkovi\u0107 MD (2021) In vitro and in vivoactivity of series of cationic dinuclearPt(II) complexes. J Inorg Biochem 225:111619. https:\/\/doi.org\/10.1016\/j.jinorgbio.2021.111619","journal-title":"J Inorg Biochem"},{"key":"2030_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/aoc.6112","author":"B Konovalov","year":"2020","unstructured":"Konovalov B, Franich AA, Jovanovi\u0107 M, Jurisevi\u0107 M, Gajovi\u0107 N, Jovanovi\u0107 M, Arsenijevi\u0107 N, Maric V, Jovanovi\u0107 I, \u017divkovi\u0107 MD, Rajkovi\u0107 S (2020) Synthesis, DNA-\/bovine serum albumin-binding affinity, and cytotoxicity of dinuclear platinum(II) complexes with 1, 6-naphthyridine-bridging ligand. Appl Organomet Chem. https:\/\/doi.org\/10.1002\/aoc.6112","journal-title":"Appl Organomet Chem"},{"key":"2030_CR25","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3389\/fchem.2019.00307","volume":"7","author":"NMP Rosa","year":"2019","unstructured":"Rosa NMP, Ferreira FHDC, Farrell NP, Costa LAS (2019) TriplatinNC and biomolecules: building models based on non-covalent interactions. Front Chem 7:307. https:\/\/doi.org\/10.3389\/fchem.2019.00307","journal-title":"Front Chem"},{"key":"2030_CR26","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/B0-08-043748-6\/09021-6","volume":"9","author":"N Farrell","year":"2003","unstructured":"Farrell N (2003) Metal complexes as drugs and chemotherapeutic agents. Compr Coord Chem II 9:809\u2013840. https:\/\/doi.org\/10.1016\/B0-08-043748-6\/09021-6","journal-title":"Compr Coord Chem II"},{"issue":"4","key":"2030_CR27","doi-asserted-by":"publisher","first-page":"272","DOI":"10.2174\/187152010791162270","volume":"10","author":"J Zhang","year":"2010","unstructured":"Zhang J, Wang L, Xing Z, Liu D, Sun J, Li X, Zhang Y (2010) Status of bi- and multi-nuclear platinum anticancer drug development. Anticancer Agents Med Chem 10(4):272\u2013282. https:\/\/doi.org\/10.2174\/187152010791162270","journal-title":"Anticancer Agents Med Chem"},{"issue":"26","key":"2030_CR28","doi-asserted-by":"publisher","first-page":"9598","DOI":"10.1021\/ic051390z","volume":"44","author":"AL Harris","year":"2005","unstructured":"Harris AL, Yang X, Hegmans A, Povirk L, Ryan JJ, Kelland L, Farrell NP (2005) Synthesis, characterization, and cytotoxicity of a novel highly charged trinuclear platinum compound. Enhancement of cellular uptake with charge. Inorg Chem 44(26):9598\u20139600. https:\/\/doi.org\/10.1021\/ic051390z","journal-title":"Inorg Chem"},{"issue":"16","key":"2030_CR29","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1021\/jm990536z","volume":"43","author":"Y Qu","year":"2000","unstructured":"Qu Y, Rauter H, Soares Fontes AP, Bandarage R, Kelland LR, Farrell N (2000) Synthesis, characterization, and cytotoxicity of trifunctional dinuclear platinum complexes: comparison of effects of geometry and polyfunctionality on biological activity. J Med Chem 43(16):3189\u20133192. https:\/\/doi.org\/10.1021\/jm990536z","journal-title":"J Med Chem"},{"issue":"21","key":"2030_CR30","doi-asserted-by":"publisher","first-page":"6781","DOI":"10.1021\/bi990124s","volume":"38","author":"V Brabec","year":"1999","unstructured":"Brabec V, Kasp\u00e1rkov\u00e1 J, Vr\u00e1na O, Nov\u00e1kov\u00e1 O, Cox JW, Qu Y, Farrell N (1999) DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent. Biochemistry 38(21):6781\u20136790. https:\/\/doi.org\/10.1021\/bi990124s","journal-title":"Biochemistry"},{"issue":"47","key":"2030_CR31","doi-asserted-by":"publisher","first-page":"15480","DOI":"10.1021\/bi00047a013","volume":"34","author":"N Farrell","year":"1995","unstructured":"Farrell N, Appleton TG, Qu Y, Roberts JD, Fontes AP, Skov KA, Wu P, Zou Y (1995) Effects of geometric isomerism and ligand substitution in bifunctional dinuclear platinum complexes on binding properties and conformational changes in DNA. Biochemistry 34(47):15480\u201315486. https:\/\/doi.org\/10.1021\/bi00047a013","journal-title":"Biochemistry"},{"issue":"7","key":"2030_CR32","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1021\/jm020004%2B","volume":"46","author":"S Komeda","year":"2003","unstructured":"Komeda S, Kalayda GV, Lutz M, Spek AL, Yamanaka Y, Sato T, Chikuma M, Reedijk J (2003) New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin. J Med Chem 46(7):1210\u20131219. https:\/\/doi.org\/10.1021\/jm020004%2B","journal-title":"J Med Chem"},{"issue":"19","key":"2030_CR33","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.1021\/ic000273v","volume":"39","author":"S Komeda","year":"2000","unstructured":"Komeda S, Lutz M, Spek AL, Chikuma M, Reedijk J (2000) New antitumor-active azole-bridged dinuclear platinum(II) complexes: synthesis, characterization, crystal structures, and cytotoxic studies. Inorg Chem 39(19):4230\u20134236. https:\/\/doi.org\/10.1021\/ic000273v","journal-title":"Inorg Chem"},{"issue":"7","key":"2030_CR34","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1073\/pnas.0737293100","volume":"100","author":"J Reedijk","year":"2003","unstructured":"Reedijk J (2003) New clues for platinum antitumor chemistry: kinetically controlled metal binding to DNA. Proc Natl Acad Sci USA 100(7):3611\u20133616. https:\/\/doi.org\/10.1073\/pnas.0737293100","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"2030_CR35","first-page":"2626","volume":"6","author":"C Manzotti","year":"2000","unstructured":"Manzotti C, Pratesi G, Menta E, Di Domenico R, Cavalletti E, Fiebig HH, Kelland LR, Farrell N, Polizzi D, Supino R, Pezzoni G, Zunino F (2000) BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatin. Clin Cancer Res 6(7):2626\u20132634","journal-title":"Clin Cancer Res"},{"key":"2030_CR36","doi-asserted-by":"publisher","DOI":"10.1039\/A903081F","author":"S Komeda","year":"1999","unstructured":"Komeda S, Ohishi H, Yamane H, Harikawa M, Sakaguchi K, Chikuma M (1999) An NMR study and crystal structure of [{cis-Pt(NH3)2(9EtG-\u03baN7)}2(\u03bc-pz)][NO3]3 (9EtG=9-ethylguanine) as a model compound for the 1,2-intrastrand GG crosslink. Dalton Trans. https:\/\/doi.org\/10.1039\/A903081F","journal-title":"Dalton Trans"},{"issue":"3","key":"2030_CR37","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1021\/jm5017686","volume":"58","author":"L Senerovic","year":"2015","unstructured":"Senerovic L, Zivkovic MD, Veselinovic A, Pavic A, Djuran MI, Rajkovic S, Nikodinovic-Runic J (2015) Synthesis and evaluation of series of diazine-bridged dinuclear platinum(II) complexes through in vitro toxicity and molecular modeling: correlation between structure and activity of Pt(II) complexes. J Med Chem 58(3):1442\u20131451. https:\/\/doi.org\/10.1021\/jm5017686","journal-title":"J Med Chem"},{"issue":"1","key":"2030_CR38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0020-1693(00)80282-0","volume":"174","author":"H Hohmann","year":"1900","unstructured":"Hohmann H, van Eldik R (1900) Rate and equilibrium data for substitution reactions of diaqua(ethylenediamine)palladium(II) with chloride in aqueous solution. Inorg Chim Acta 174(1):87\u201392. https:\/\/doi.org\/10.1016\/S0020-1693(00)80282-0","journal-title":"Inorg Chim Acta"},{"issue":"6","key":"2030_CR39","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.poly.2010.12.039","volume":"30","author":"MD \u017divkovi\u0107","year":"2011","unstructured":"\u017divkovi\u0107 MD, A\u0161anin DP, Rajkovi\u0107 S, Djuran MI (2011) Hydrolysis of the amide bond in N-acetylated l-methionylglycine catalyzed by various platinum(II) complexes under physiologically relevant conditions. Polyhedron 30(6):947\u2013952. https:\/\/doi.org\/10.1016\/j.poly.2010.12.039","journal-title":"Polyhedron"},{"key":"2030_CR40","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.poly.2012.12.037","volume":"5","author":"DP A\u0161anin","year":"2013","unstructured":"A\u0161anin DP, \u017divkovi\u0107 MD, Rajkovi\u0107 S, War\u017aajtis B, Rychlewska U, Djuran MI (2013) Crystallographic evidence of anion\u22ef\u03c0 interactions in the pyrazine bridged {[Pt(en)Cl]2(\u03bc-pz)}Cl2 complex and a comparative study of the catalytic ability of mononuclear and binuclear platinum(II) complexes in the hydrolysis of N-acetylated l-methionylglycine. Polyhedron 5:255\u2013262. https:\/\/doi.org\/10.1016\/j.poly.2012.12.037","journal-title":"Polyhedron"},{"key":"2030_CR41","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.poly.2013.09.008","volume":"67","author":"S Rajkovi\u0107","year":"2014","unstructured":"Rajkovi\u0107 S, Rychlewska U, War\u017cajtis B, A\u0161anin DP, \u017divkovi\u0107 MD, Djuran MI (2014) Disparate behavior of pyrazine and pyridazine platinum(II) dimers in the hydrolysis of histidine\u2014and methionine-containing peptides and unique crystal structure of {[Pt(en)Cl]2(\u03bc-pydz)}Cl2 with a pair of NH...Cl\u2013...HN hydrogen bonds supporting the pyridazine bridge. Polyhedron 67:279\u2013285. https:\/\/doi.org\/10.1016\/j.poly.2013.09.008","journal-title":"Polyhedron"},{"key":"2030_CR42","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1021\/ja00365a069","volume":"104","author":"RP Hertzberg","year":"1982","unstructured":"Hertzberg RP, Dervan PB (1982) Cleavage of double helical DNA by methidium-propyl-EDTA-iron(II). J Am Chem Soc 104:313\u2013315. https:\/\/doi.org\/10.1021\/ja00365a069","journal-title":"J Am Chem Soc"},{"key":"2030_CR43","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.saa.2013.03.067","volume":"111","author":"S Bi","year":"2013","unstructured":"Bi S, Pang B, Zhao T, Wang T, Wang Y, Yan L (2013) Binding characteristics of salbutamol with DNA by spectral methods. Spectrochim Acta A Mol Biomol Spectrosc 111:182\u2013187. https:\/\/doi.org\/10.1016\/j.saa.2013.03.067","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"issue":"40","key":"2030_CR44","doi-asserted-by":"publisher","first-page":"10269","DOI":"10.1021\/j100142a004","volume":"97","author":"CI Bayly","year":"1993","unstructured":"Bayly CI, Cieplak P, Cornell WD, Kollman PA (1993) A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model. J Phys Chem 97(40):10269\u201310280. https:\/\/doi.org\/10.1021\/j100142a004","journal-title":"J Phys Chem"},{"issue":"4","key":"2030_CR45","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1073\/pnas.78.4.2179","volume":"78","author":"HR Drew","year":"1981","unstructured":"Drew HR, Wing RM, Takano T, Broka C, Tanaka S, Itakura K, Dickerson RE (1981) Structure of a B-DNA dodecamer: conformation and dynamics. Proc Natl Acad Sci USA 78(4):2179\u20132183. https:\/\/doi.org\/10.1073\/pnas.78.4.2179","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 10","key":"2030_CR46","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1107\/S0907444912027047","volume":"68","author":"A Bujacz","year":"2012","unstructured":"Bujacz A (2012) Structures of bovine, equine and leporine serum albumin. Acta Crystallogr D Biol Crystallogr 68(Pt 10):1278\u20131289. https:\/\/doi.org\/10.1107\/S0907444912027047","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"12","key":"2030_CR47","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.1016\/j.bbagen.2013.06.032","volume":"1830","author":"ZM Wang","year":"2013","unstructured":"Wang ZM, Ho JX, Ruble JR, Rose J, R\u00fcker F, Ellenburg M, Murphy R, Click J, Soistman E, Wilkerson L, Carter DC (2013) Structural studies of several clinically important oncology drugs in complex with human serum albumin. Biochim Biophys Acta 1830(12):5356\u20135374. https:\/\/doi.org\/10.1016\/j.bbagen.2013.06.032","journal-title":"Biochim Biophys Acta"},{"issue":"16","key":"2030_CR48","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30(16):2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256","journal-title":"J Comput Chem"},{"key":"2030_CR49","unstructured":"Dassault Syst\u00e8mes BIOVIA (2016) Discovery studio modeling environment, Release 2017, San Diego"},{"issue":"46","key":"2030_CR50","doi-asserted-by":"publisher","first-page":"28195","DOI":"10.18632\/oncotarget.25610","volume":"9","author":"M Jurisevic","year":"2018","unstructured":"Jurisevic M, Arsenijevic A, Pantic J, Gajovic N, Milovanovic J, Milovanovic M, Poljarevic J, Sabo T, Vojvodic D, Radosavljevic GD, Arsenijevic N (2018) The organic ester O,O\u2032-diethyl-(S,S)-ethylenediamine-N,N\u2032-di-2-(3-cyclohexyl)propanoate dihydrochloride attenuates murine breast cancer growth and metastasis. Oncotarget 9(46):28195\u201328212. https:\/\/doi.org\/10.18632\/oncotarget.25610","journal-title":"Oncotarget"},{"issue":"1","key":"2030_CR51","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13058-019-1204-2","volume":"21","author":"JO Lee","year":"2019","unstructured":"Lee JO, Kang MJ, Byun WS, Kim SA, Seo IH, Han JA, Moon JW, Kim JH, Kim SJ, Lee EJ, In Park S, Park SH, Kim HS (2019) Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51. Breast Cancer Res 21(1):115. https:\/\/doi.org\/10.1186\/s13058-019-1204-2","journal-title":"Breast Cancer Res"},{"issue":"15","key":"2030_CR52","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.1021\/bi00066a035","volume":"32","author":"WD Wilson","year":"1993","unstructured":"Wilson WD, Ratmeyer L, Zhao M, Strekowski L, Boykin D (1993) The search for structure-specific nucleic acid-interactive drugs: effects of compound structure on RNA versus DNA interaction strength. Biochemistry 32(15):4098\u20134104. https:\/\/doi.org\/10.1021\/bi00066a035","journal-title":"Biochemistry"},{"issue":"10","key":"2030_CR53","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1039\/D0NA00528B","volume":"2","author":"K Englert","year":"2020","unstructured":"Englert K, Hendi R, Robbs PH, Rees NV, Robinson APG, Tucker JHR (2020) Cisplatin adducts of DNA as precursors for nanostructured catalyst materials. Nanoscale Adv 2(10):4491\u20134497. https:\/\/doi.org\/10.1039\/D0NA00528B","journal-title":"Nanoscale Adv"},{"issue":"3","key":"2030_CR54","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.jinorgbio.2004.12.014","volume":"99","author":"S Dhar","year":"2005","unstructured":"Dhar S, Nethaji M, Chakravarty AR (2005) Effect of charge transfer bands on the photo-induced DNA cleavage activity of [1-(2-thiazolylazo)-2-naphtholato]copper(II) complexes. J Inorg Biochem 99(3):805\u2013812. https:\/\/doi.org\/10.1016\/j.jinorgbio.2004.12.014","journal-title":"J Inorg Biochem"},{"key":"2030_CR55","doi-asserted-by":"crossref","unstructured":"Salive ME, Cornoni-Huntley J, Phillips CL, Guralnik JM, Cohen HJ, Ostfeld AM, Wallace RB (1992) Serum albumin in older persons: relationship with age and health status. J Clin Epidemiol 45(3):213\u2013221. https:\/\/www.jclinepi.com\/article\/0895-4356(92)90081-W\/pdf","DOI":"10.1016\/0895-4356(92)90081-W"},{"key":"2030_CR56","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.molstruc.2016.09.036","volume":"1128","author":"OA Chaves","year":"2017","unstructured":"Chaves OA, da Silva VA, Sant\u2019Anna CMR, Ferreiraa ABB, Ribeiro TAN, De-Carvalho MG, Cesarin-Sobrinho D, Netto-Ferreira JC (2017) Binding studies of lophirone B with bovine serum albumin (BSA): combination of spectroscopic and molecular docking techniques. J Mol Struct 1128:606\u2013611. https:\/\/doi.org\/10.1016\/j.molstruc.2016.09.036","journal-title":"J Mol Struct"},{"key":"2030_CR57","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jphotobiol.2016.06.025","volume":"162","author":"JH Shi","year":"2016","unstructured":"Shi JH, Pan DQ, Wang XX, Liu TT, Jiang M, Wang Q (2016) Characterizing the binding interaction between antimalarial artemether (AMT) and bovine serum albumin (BSA): spectroscopic and molecular docking methods. J Photochem Photobiol B 162:14\u201323. https:\/\/doi.org\/10.1016\/j.jphotobiol.2016.06.025","journal-title":"J Photochem Photobiol B"},{"key":"2030_CR58","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.saa.2017.07.040","volume":"188","author":"JH Shi","year":"2018","unstructured":"Shi JH, Zhou KL, Lou YY, Pan DQ (2018) Multi-spectroscopic and molecular modeling approaches to elucidate the binding interaction between bovine serum albumin and darunavir, a HIV protease inhibitor. Spectrochim Acta A Mol Biomol Spectrosc 188:362\u2013371. https:\/\/doi.org\/10.1016\/j.saa.2017.07.040","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"issue":"18","key":"2030_CR59","doi-asserted-by":"publisher","first-page":"6252","DOI":"10.1039\/C3DT50268F","volume":"42","author":"G Psomas","year":"2013","unstructured":"Psomas G, Kessissoglou DP (2013) Quinolones and non-steroidal anti-inflammatory drugs interacting with copper(II), nickel(II), cobalt(II) and zinc(II): structural features, biological evaluation and perspectives. Dalton Trans 42(18):6252\u20136276. https:\/\/doi.org\/10.1039\/C3DT50268F","journal-title":"Dalton Trans"},{"issue":"20","key":"2030_CR60","doi-asserted-by":"publisher","first-page":"8208","DOI":"10.1021\/ic700755p","volume":"46","author":"V Rajendiran","year":"2007","unstructured":"Rajendiran V, Karthik R, Palaniandavar M, Stoeckli-Evans H, Periasamy VS, Akbarsha MA, Srinag BS, Krishnamurthy H (2007) Mixed-ligand copper(II)-phenolate complexes: effect of coligand on enhanced DNA and protein binding, DNA cleavage, and anticancer activity. Inorg Chem 46(20):8208\u20138221. https:\/\/doi.org\/10.1021\/ic700755p","journal-title":"Inorg Chem"},{"issue":"22","key":"2030_CR61","doi-asserted-by":"publisher","first-page":"5559","DOI":"10.3390\/ijms20225559","volume":"20","author":"B Swanepoel","year":"2019","unstructured":"Swanepoel B, Nitulescu GM, Olaru OT, Venables L, van de Venter M (2019) Anti-cancer activity of a 5-aminopyrazole derivative lead compound (BC-7) and potential synergistic cytotoxicity with cisplatin against human cervical cancer cells. Int J Mol Sci 20(22):5559. https:\/\/doi.org\/10.3390\/ijms20225559","journal-title":"Int J Mol Sci"},{"key":"2030_CR62","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"issue":"2","key":"2030_CR63","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3390\/ijms19020448","volume":"19","author":"CM Pfeffer","year":"2018","unstructured":"Pfeffer CM, Singh ATK (2018) Apoptosis: a target for anticancer therapy. Int J Mol Sci 19(2):448. https:\/\/doi.org\/10.3390\/ijms19020448","journal-title":"Int J Mol Sci"},{"key":"2030_CR64","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4137\/BMI.S39445","volume":"11","author":"V Velma","year":"2016","unstructured":"Velma V, Dasari SR, Tchounwou PB (2016) low doses of cisplatin induce gene alterations, cell cycle arrest, and apoptosis in human promyelocytic leukemia cells. Biomark Insights 11:113\u2013121. https:\/\/doi.org\/10.4137\/BMI.S39445","journal-title":"Biomark Insights"},{"issue":"6","key":"2030_CR65","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/bjc.2015.85","volume":"112","author":"J Lopez","year":"2015","unstructured":"Lopez J, Tait SW (2015) Mitochondrial apoptosis: killing cancer using the enemy within. Br J Cancer 112(6):957\u2013962. https:\/\/doi.org\/10.1038\/bjc.2015.85","journal-title":"Br J Cancer"},{"issue":"9","key":"2030_CR66","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.3109\/10428194.2013.855307","volume":"55","author":"S Zaman","year":"2014","unstructured":"Zaman S, Wang R, Gandhi V (2014) Targeting the apoptosis pathway in hematologic malignancies. Leuk Lymphoma 55(9):1980\u20131992. https:\/\/doi.org\/10.3109\/10428194.2013.855307","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"2030_CR67","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1681\/asn.v134858","volume":"13","author":"MS Park","year":"2002","unstructured":"Park MS, De Leon M, Devarajan P (2002) Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways. J Am Soc Nephrol 13(4):858\u2013865. https:\/\/doi.org\/10.1681\/asn.v134858","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2030_CR68","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/nrm.2016.149","volume":"18","author":"R Weinlich","year":"2017","unstructured":"Weinlich R, Oberst A, Beere HM, Green DR (2017) Necroptosis in development, inflammation and disease. Nat Rev Mol Cell Biol 18(2):127\u2013136. https:\/\/doi.org\/10.1038\/nrm.2016.149","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2030_CR69","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.cellsig.2017.01.004","volume":"31","author":"Y Xu","year":"2017","unstructured":"Xu Y, Ma HB, Fang YL, Zhang ZR, Shao J, Hong M, Huang CJ, Liu J, Chen RQ (2017) Cisplatin-induced necroptosis in TNF\u03b1 dependent and independent pathways. Cell Signal 31:112\u2013123. https:\/\/doi.org\/10.1016\/j.cellsig.2017.01.004","journal-title":"Cell Signal"},{"issue":"4","key":"2030_CR70","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/bies.950190408","volume":"19","author":"CY Gao","year":"1997","unstructured":"Gao CY, Zelenka PS (1997) Cyclins, cyclin-dependent kinases and differentiation. BioEssays 19(4):307\u2013315. https:\/\/doi.org\/10.1002\/bies.950190408","journal-title":"BioEssays"},{"issue":"11\u201312","key":"2030_CR71","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1177\/1947601913479022","volume":"3","author":"MC Casimiro","year":"2012","unstructured":"Casimiro MC, Crosariol M, Loro E, Li Z, Pestell RG (2012) Cyclins and cell cycle control in cancer and disease. Genes Cancer 3(11\u201312):649\u2013657. https:\/\/doi.org\/10.1177\/1947601913479022","journal-title":"Genes Cancer"},{"key":"2030_CR72","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12935-019-0865-3","volume":"19","author":"B Wang","year":"2019","unstructured":"Wang B, Wang Z, Han L, Gong S, Wang Y, He Z, Feng Y, Yang Z (2019) Prognostic significance of cyclin D3 expression in malignancy patients: a meta-analysis. Cancer Cell Int 19:158. https:\/\/doi.org\/10.1186\/s12935-019-0865-3","journal-title":"Cancer Cell Int"},{"key":"2030_CR73","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12935-015-0245-6","volume":"15","author":"Y Chi","year":"2015","unstructured":"Chi Y, Huang S, Liu M, Guo L, Shen X, Wu J (2015) Cyclin D3 predicts disease-free survival in breast cancer. Cancer Cell Int 15:89. https:\/\/doi.org\/10.1186\/s12935-015-0245-6","journal-title":"Cancer Cell Int"},{"issue":"9","key":"2030_CR74","first-page":"5170","volume":"12","author":"W Pang","year":"2020","unstructured":"Pang W, Li Y, Guo W, Shen H (2020) Cyclin E: a potential treatment target to reverse cancer chemoresistance by regulating the cell cycle. Am J Transl Res 12(9):5170\u20135187","journal-title":"Am J Transl Res"},{"issue":"20","key":"2030_CR75","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1056\/nejmoa021153","volume":"347","author":"K Keyomarsi","year":"2002","unstructured":"Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, Hortobagyi GN, Bedrosian I, Knickerbocker C, Toyofuku W, Lowe M, Herliczek TW, Bacus SS (2002) Cyclin E and survival in patients with breast cancer. N Engl J Med 347(20):1566\u20131575. https:\/\/doi.org\/10.1056\/nejmoa021153","journal-title":"N Engl J Med"},{"issue":"2","key":"2030_CR76","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2006.11.049","volume":"128","author":"I Chu","year":"2007","unstructured":"Chu I, Sun J, Arnaout A, Kahn H, Hanna W, Narod S, Sun P, Tan CK, Hengst L, Slingerland J (2007) p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2. Cell 128(2):281\u2013294. https:\/\/doi.org\/10.1016\/j.cell.2006.11.049","journal-title":"Cell"},{"issue":"24","key":"2030_CR77","first-page":"5441","volume":"57","author":"Y Katayose","year":"1997","unstructured":"Katayose Y, Kim M, Rakkar AN, Li Z, Cowan KH, Seth P (1997) Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27. Cancer Res 57(24):5441\u20135445","journal-title":"Cancer Res"},{"issue":"50","key":"2030_CR78","doi-asserted-by":"publisher","first-page":"6462","DOI":"10.1038\/onc.2008.312","volume":"27","author":"B Hoffman","year":"2008","unstructured":"Hoffman B, Liebermann DA (2008) Apoptotic signaling by c-MYC. Oncogene 27(50):6462\u20136472. https:\/\/doi.org\/10.1038\/onc.2008.312","journal-title":"Oncogene"},{"issue":"1","key":"2030_CR79","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12943-020-01291-6","volume":"20","author":"SK Madden","year":"2021","unstructured":"Madden SK, de Araujo AD, Gerhardt M, Fairlie DP, Mason JM (2021) Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc. Mol Cancer 20(1):3. https:\/\/doi.org\/10.1186\/s12943-020-01291-6","journal-title":"Mol Cancer"},{"issue":"1","key":"2030_CR80","doi-asserted-by":"publisher","first-page":"18693","DOI":"10.1038\/s41598-019-54917-1","volume":"9","author":"L Garc\u00eda-Guti\u00e9rrez","year":"2019","unstructured":"Garc\u00eda-Guti\u00e9rrez L, Bretones G, Molina E, Arechaga I, Symonds C, Acosta JC, Blanco R, Fern\u00e1ndez A, Alonso L, Sicinski P, Barbacid M, Santamar\u00eda D, Le\u00f3n J (2019) Myc stimulates cell cycle progression through the activation of Cdk1 and phosphorylation of p27. Sci Rep 9(1):18693. https:\/\/doi.org\/10.1038\/s41598-019-54917-1","journal-title":"Sci Rep"},{"issue":"5","key":"2030_CR81","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.bbagrm.2014.03.013","volume":"1849","author":"G Bretones","year":"2015","unstructured":"Bretones G, Delgado MD, Le\u00f3n J (2015) Myc and cell cycle control. Biochim Biophys Acta 1849(5):506\u2013516. https:\/\/doi.org\/10.1016\/j.bbagrm.2014.03.013","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"2030_CR82","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1158\/0008-5472.can-18-2738","volume":"79","author":"M Song","year":"2019","unstructured":"Song M, Bode AM, Dong Z, Lee MH (2019) AKT as a therapeutic target for cancer. Cancer Res 79(6):1019\u20131031. https:\/\/doi.org\/10.1158\/0008-5472.can-18-2738","journal-title":"Cancer Res"},{"issue":"4","key":"2030_CR83","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.ejca.2008.11.044","volume":"45","author":"YO Al-Bazz","year":"2009","unstructured":"Al-Bazz YO, Underwood JC, Brown BL, Dobson PR (2009) Prognostic significance of Akt, phospho-Akt and BAD expression in primary breast cancer. Eur J Cancer 45(4):694\u2013704. https:\/\/doi.org\/10.1016\/j.ejca.2008.11.044","journal-title":"Eur J Cancer"},{"issue":"10","key":"2030_CR84","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1158\/0008-5472.can-11-3605","volume":"72","author":"WB Tsai","year":"2012","unstructured":"Tsai WB, Aiba I, Long Y, Lin HK, Feun L, Savaraj N, Kuo MT (2012) Activation of Ras\/PI3K\/ERK pathway induces c-Myc stabilization to upregulate argininosuccinate synthetase, leading to arginine deiminase resistance in melanoma cells. Cancer Res 72(10):2622\u20132633. https:\/\/doi.org\/10.1158\/0008-5472.can-11-3605","journal-title":"Cancer Res"},{"issue":"3","key":"2030_CR85","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/sj.leu.2402824","volume":"17","author":"F Chang","year":"2003","unstructured":"Chang F, Lee JT, Navolanic PM, Steelman LS, Shelton JG, Blalock WL, Franklin RA, McCubrey JA (2003) Involvement of PI3K\/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 17(3):590\u2013603. https:\/\/doi.org\/10.1038\/sj.leu.2402824","journal-title":"Leukemia"},{"issue":"56","key":"2030_CR86","doi-asserted-by":"publisher","first-page":"8983","DOI":"10.1038\/sj.onc.1207115","volume":"22","author":"TF Franke","year":"2003","unstructured":"Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C (2003) PI3K\/Akt and apoptosis: size matters. Oncogene 22(56):8983\u20138998. https:\/\/doi.org\/10.1038\/sj.onc.1207115","journal-title":"Oncogene"},{"issue":"9","key":"2030_CR87","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","volume":"11","author":"R Liu","year":"2020","unstructured":"Liu R, Chen Y, Liu G, Li C, Song Y, Cao Z, Li W, Hu J, Lu C, Liu Y (2020) PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers. Cell Death Dis 11(9):797. https:\/\/doi.org\/10.1038\/s41419-020-02998-6","journal-title":"Cell Death Dis"},{"key":"2030_CR88","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jinorgbio.2013.07.014","volume":"128","author":"CD Sanghvi","year":"2013","unstructured":"Sanghvi CD, Olsen PM, Elix C, Peng SB, Wang D, Chen ZG, Shin DM, Hardcastle KI, MacBeth CE, Eichler JF (2013) Antitumor properties of five-coordinate gold(III) complexes bearing substituted polypyridyl ligands. J Inorg Biochem 128:68\u201376. https:\/\/doi.org\/10.1016\/j.jinorgbio.2013.07.014","journal-title":"J Inorg Biochem"},{"issue":"6","key":"2030_CR89","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1007\/s10637-010-9461-z","volume":"29","author":"J Moretto","year":"2011","unstructured":"Moretto J, Chauffert B, Ghiringhelli F, Aldrich-Wright JR, Bouyer F (2011) Discrepancy between in vitro and in vivo antitumor effect of a new platinum(II) metallointercalator. Invest New Drugs 29(6):1164\u20131176. https:\/\/doi.org\/10.1007\/s10637-010-9461-z","journal-title":"Invest New Drugs"},{"issue":"9","key":"2030_CR90","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1021\/jm7016072","volume":"51","author":"S Kemp","year":"2008","unstructured":"Kemp S, Wheate NJ, Pisani MJ, Aldrich-Wright JR (2008) Degradation of bidentate-coordinated platinum(II)-based DNA intercalators by reduced l-glutathione. J Med Chem 51(9):2787\u20132794. https:\/\/doi.org\/10.1021\/jm7016072","journal-title":"J Med Chem"}],"container-title":["JBIC Journal of Biological Inorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00775-023-02030-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00775-023-02030-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00775-023-02030-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T03:48:26Z","timestamp":1712634506000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00775-023-02030-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["2030"],"URL":"https:\/\/doi.org\/10.1007\/s00775-023-02030-0","relation":{},"ISSN":["1432-1327"],"issn-type":[{"value":"1432-1327","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,15]]},"assertion":[{"value":"4 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}